Tamsulosin

August 22, 2016August 22, 2016

Powder Treatment for BPH, Tamsulosin DRS, to Get Speedy FDA Review

News

Aspen Park Pharmaceuticals (APP) announced that the U.S. Food and Drug Administration (FDA) has agreed to an expedited regulatory review process for Tamsulosin DRS, the pharmaceutical’s lead powder formulation of the widely ... Read more

August 3, 2016

BPH Patients Respond Better to Combo Therapy of Detrol and Cardura, According to Study

News

Researchers assessed the efficacy and safety of a combination therapy of two different α-blockers, Cardura (doxazosin) and Flomax (tamsulosin), with Detrol (tolterodine), as evidence supports the superiority of this strategy over ... Read more

July 26, 2016

Literature on Newer Drugs for LUTS Attributed to BPH Reviewed by Researchers

News

The U.S. Agency for Healthcare Research and Quality has published a review of the available evidence on the newer medicines for the treatment of lower urinary tract symptoms (LUTS) attributed ... Read more

July 11, 2016July 18, 2016

The Use of Tamsulosin In Prostate Enlargement

Medication is one of the treatment options used to address benign prostatic hyperplasia (BPH). Among the medicines approved for BPH is tamsulosin, a drug from a group of alpha blockers that ... Read more

May 11, 2016May 11, 2016

3 Drugs Often Used to Treat BPH/LUTS Reported in Study to Be Equally Effective

News

A study published in the Indian Journal of Pharmacology showed that alfuzosin, tamsulosin, and silodosin, three of the most widely used drugs for the treatment of benign prostatic hyperplasia (BPH) ... Read more

February 15, 2016

Last Week’s Hot Topic on BPH

Last week’s hot topic on BPH was BPH Combo Tamsulosin-Dutasteride Treatment Superior to Monotherapy, Review Finds written by Magdalena Kegel. This article is focused on the combination treatment with tamsulosin and dutasteride, which was superior ... Read more

February 8, 2016February 8, 2016

BPH Combo Tamsulosin-Dutasteride Treatment Superior to Monotherapy, Review Finds

News

Combination treatment with tamsulosin and dutasteride was superior to monotherapy with either compound in reducing benign prostatic hyperplasia (BPH) symptoms as well as the risk for disease progression. The combination is also most beneficial ... Read more